Michael A Metzger's Net Worth

$8.5 Million

Estimate Recalculated Feb 9, 2024 04:13PM EST

Who is Michael A Metzger?

Michael A Metzger has an estimated net worth of $8.5 Million. This is based on reported shares across multiple companies, which include Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, Regado Biosciences Inc, and RESPONSE GENETICS INC.

SEC CIK

Michael A Metzger's CIK is 0001507220

Past Insider Trading and Trends

2021 was Michael A Metzger's most active year for acquiring shares with 17 total transactions. Michael A Metzger's most active month to acquire stocks was the month of January. 2022 was Michael A Metzger's most active year for disposing of shares, totalling 32 transactions. Michael A Metzger's most active month to dispose stocks was the month of June. 2023 saw Michael A Metzger paying a total of $11,743,518.42 for 495,959 shares, this is the most they've acquired in one year. In 2020 Michael A Metzger cashed out on 230,000 shares for a total of $2,375,922.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.665

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+828.19%
146.25K
—
—
163.91K
Feb 7
Form 4
—
0
$17.01
-$126,678.81
17.66K
Scheduled
Feb 6
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
$17.03
-$268,162.09
17.66K
Scheduled
Oct 6
Form 4
—
0
$16.90
-$548,735.87
17.66K
Scheduled
Sep 30 - Oct 4
Form 4
—
0
$13.72
-$463,771.99
17.66K
Scheduled
Jul 25
Form 4
—
0
$13.73
-$222,011.75
17.66K
Scheduled
Jul 6 - Jul 7
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
$13.79
-$1,050,500.53
17.66K
Scheduled
Dec 16 - Dec 20
Form 4
—
0
$12.74
-$462,276.28
17.66K
Scheduled
Dec 13
Form 4
—
0
$13.18
-$728,959.58
17.66K
Scheduled
Oct 25 - Oct 26
Form 4
—
0
$13.36
-$300,885.45
17.66K
Scheduled
Sep 27
Form 4
—
0
$13.21
-$439,607.06
17.66K
Scheduled
Sep 20 - Sep 22
Form 4
—
0
$13.16
-$726,832.97
17.66K
Scheduled
Sep 13 - Sep 14
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
$13.70
-$194,799.00
17.66K
Scheduled
Feb 1
Form 4
—
0
$15.09
-$236,512.50
17.66K
Scheduled
Dec 1
Form 4
—
0
$13.76
-$1,311,410.00
17.66K
Scheduled
Nov 4
Form 4
+564.12%
15K
—
—
17.66K
Feb 12
Form 4
—
0
—
—
0
Jul 4
Form 4
∞
2.66K
$4.76
$12,656.84
2.66K
Jan 31 - Feb 6
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 6
Form 3
—
0
—
—
0
No matching records found

CTI BIOPHARMA CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Apr 5
Form 4
—
0
$3.27
-$424,047.47
0
Scheduled
Nov 8
Form 4
-100.00%
-20.12K
$6.51
-$130,994.92
0
Scheduled
Jul 7
Form 4
—
0
$3.46
-$479,106.51
20.12K
Scheduled
Jul 5
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 17
Form 4
∞
20.12K
—
—
20.12K
Jan 20
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Jan 20
Form 3
—
0
—
—
0
No matching records found

Regado Biosciences Inc No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Dec 3
Form 3
—
0
—
—
0
No matching records found

RESPONSE GENETICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 30
Form 4
∞
1K
$1.50
$1,500.00
1K
Feb 2
Form 4
—
0
—
—
0
Oct 13
Form 4
—
0
—
—
0
Apr 12
Form 4
—
0
—
—
0
Dec 1
Form 3
—
0
—
—
0
No matching records found